NANOMED NEWS

Inside Therapeutics raises €1M to accelerate its growth, withAquiti Gestion joining its capital.Press releaseDownload Full Press Release in EnglishTelecharger communiqué complet en Francais Angoulême, France, June 3rd, 2025. Inside Therapeutics, an innovative French player in nanomedicine, announces the successful closing of a €1 million fundraising round from Aquiti Gestion, via its AVA1 fund, and its…

A new milestone in TAMARA’s expansion achieved  At Inside Therapeutics, we’re excited to officially announce our partnership with Microfluidics from IDEX MPT as our exclusive distributor for the TAMARA nanoparticle formulation system in the USA and Canada.  This collaboration marks a major milestone in TAMARA’s global expansion. Following a successful across Europe – with strong adoption…

Inside Therapeutics raises €1.3M to accelerate patient access to RNA therapiesPress releaseDownload Full Press Release in EnglishTelecharger communiqué complet en Francais Angoulême, France, June 20, 2024. Inside Therapeutics, a company that designs, develops and markets systems for encapsulating RNA for therapeutic purposes in lipid nanoparticles, has raised €1.3 million from Newfund Heka, Newfund NAEH, Skalepark…

This research summary focuses on analyzing how oligonucleotide/ RNA size and the types of lipids used influence the key properties of lipid nanoparticles synthesized via microfluidic techniques.The peer-reviewed article “A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient” was originally published in Scientific Reports, in 2024…

Revolutionizing Gene Therapy: Screening Lipid Nanoparticles for optimal delivery of mRNA and CRISPR-Cas9The world of medical science is witnessing groundbreaking and fast paced transformation as researchers delve into the potential of lipid nanoparticles (LNPs) for the delivery of messenger RNA (mRNA) and gene editing material.Researchers at MIT and the University of Toronto have recently released…

Pancreatic cancer  Pancreatic cancer is a deadly disease with a poor prognosis – in the order of 10% at 5 years, which goes up to 20% when the cancer can be removed. Considering this low recovering rate, researchers at Memorial Sloan Kettering Cancer Center (MSK) are conducting a clinical trial to test the use of…

02/05/2023Dialysis: a key and underestimated factor for the synthesis of lipid nanoparticle by microfluidicsDISCOVERThis research summary aims at describing the influence of the critical process parameters on the main characteristics of lipid nanoparticles when synthesized by microfluidics, with a specific focus on the influence of dialysis.The peer reviewed article “Dialysis is a key factor modulating…

First-in class science leads to the convergence of nanomedicine and genetics In a comment published in the current March issue of Nature Nanotechnology, J. Conde, R. Langer and J. Rueff went back on the historical convergence which is currently leading to a health revolution. By combining advanced genetic tools such as non-immunogenic modified mRNA (Karikó,…